
    
      The study was designed such that 30 participants would be consented/enrolled into the trial.
      The intervention would only be applied if the participant developed a viral illness that met
      eligibility criteria during the study period.

      Only 10 of the 30 ppt. consented/enrolled developed a virus and were then treated according
      to study arm.

      A more detailed description can be obtained by contacting Astra Zeneca
    
  